CD19.CAR Allogeneic NKT for Patients With Relapsed or Refractory B-Cell Malignancies (ANCHOR)

NCT03774654 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Refractory B-Cell Non-Hodgkin Lymphoma
Refractory B-Cell Small Lymphocytic Lymphoma
Relapsed Adult ALL
Relapsed CLL
Relapsed Non Hodgkin Lymphoma

Interventions

GENETIC: CD19.CAR-aNKT cells

Sponsor

Baylor College of Medicine

Collaborators

[object Object]
[object Object]
[object Object]